]Norepinephrine overflow from isolated rat atria is also inhibited by norepinephrine, but this effect is antagonized by yohimbine and not by prazosin. We suggest that the release of acetylcholine from cardiac parasympathetic neurons can be regulated through an «i -adrenergic receptor, and that this mechanism may underly, at least in part, the relative lack of effects of prazosin on heart rate. (Circ Res 56: 763-766, 1985) ACETYLCHOLINE (ACh) is the neurotransmitter of the cardiac vagus and is the chemical signal by which parasympathetic activity modulates heart rate, impulse conduction, and contractility. The activity of the vagus nerve is known to be controlled centrally, but the possibility that there is local modulation of ACh release from cardiac parasympathetic neurons has not been adequately explored. We recently found that ACh overflow from parasympathetic neurons in isolated rat atria was inhibited by the sympathetic neurotransmitter norepinephrine and by the sympathetic hormone epinephrine (Wetzel and Brown, 1985). Further studies with selective agonists and antagonists are reported here. These studies demonstrate that the adrenergic receptor regulating ACh release does not have the a 2 -adrenergic characteristics typical of presynaptic receptors but, instead, has the pharmacological properties of an «,-adrenergic receptor (Starke et al., 1975;Wikberg, 1978;Hoffman and Lefkowitz, 1980;Langer, 1981 (Wetzel and Brown, 1985).Eight individual atria were superfused in each experiment. The release of [
Results and DiscussionThe naturally occurring catecholamines epinephrine (EPI) and norepinephrine (NE) inhibit the K + -stimulated overflow of 3 H by as much as 60%, decreasing the S 2 :S, ratio to -0 . 3 (Table 1). The catecholamine concentrations that give half-maximal inhibition are 2 HM and 6 //M for EPI and NE, respectively. In contrast, isoproterenol does not inhibit K + -stimulated 3 H overflow (Table 1). These data indicate that NE inhibits ACh overflow through activation of an a-rather than a /3-adrenergic receptor. This is supported by our previous observation that the effect of NE is blocked by yohimbine, an «-adrenergic receptor antagonist, but not by the /?-adrenergic receptor antagonist propranolol (Wetzel and Brown, 1985).